Yabusaki Norimitsu, Yamada Suguru, Murai Toshifumi, Kanda Mitsuro, Kobayashi Daisuke, Tanaka Chie, Fujii Tsutomu, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Nomoto Shuji, Fujiwara Michitaka, Kodera Yasuhiro
Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.
Mol Clin Oncol. 2015 Mar;3(2):435-441. doi: 10.3892/mco.2014.462. Epub 2014 Nov 20.
Zinc-finger E-box binding homeobox 1 (ZEB1) is an important regulator of epithelial-to-mesenchymal transition and is associated with various types of metastasis. Gastric cancer patients often develop peritoneal carcinomatosis, of which the detection of free cancer cells in the peritoneal washes is an important predictor. We analyzed the correlation of ZEB1 mRNA levels in the peritoneal washing (pZEB1) with clinicopathological variables and survival in 107 gastric cancer patients who underwent surgery and peritoneal washing cytology. Reverse transcription-polymerase chain reaction was performed to quantify pZEB1. The patients were classified into the pZEB1 (n=27) and the pZEB1 (n=80) groups based on their pZEB1 expression. pZEB1 was statistically correlated with pathological T stage (P=0.03) and vascular involvement (P=0.03). At 5 years, the disease-specific survival was 36.4% for the pZEB1 group and 64.7% for the pZEB1 group (P=0.02), whereas the disease-free survival rate was 46.9% for the pZEB1 group and 83.0% for the pZEB1 group (P=0.03). When subclassified into 4 categories based on washing cytology and pZEB1, survival was significantly lower in the pZEB1 compared to the pZEB1 group (cytology -negative group, P=0.01; cytology -positive group, P=0.13). Therefore, pZEB1 may add valuable information to conventional peritoneal washing cytology as a prognostic determinant in gastric cancer.
锌指E盒结合同源框蛋白1(ZEB1)是上皮-间质转化的重要调节因子,与多种类型的转移相关。胃癌患者常发生腹膜转移癌,其中检测腹腔灌洗液中的游离癌细胞是一项重要的预后指标。我们分析了107例行手术及腹腔灌洗细胞学检查的胃癌患者腹腔灌洗液中ZEB1 mRNA水平(pZEB1)与临床病理变量及生存情况的相关性。采用逆转录-聚合酶链反应对pZEB1进行定量分析。根据pZEB1表达情况将患者分为pZEB1高表达组(n = 27)和pZEB1低表达组(n = 80)。pZEB1与病理T分期(P = 0.03)及血管侵犯(P = 0.03)具有统计学相关性。5年时,pZEB1高表达组的疾病特异性生存率为36.4%,pZEB1低表达组为64.7%(P = 0.02);无病生存率方面,pZEB1高表达组为46.9%,pZEB1低表达组为83.0%(P = 0.03)。根据灌洗细胞学及pZEB1分为4类时,pZEB1高表达组的生存率显著低于pZEB1低表达组(细胞学阴性组,P = 0.01;细胞学阳性组,P = 0.13)。因此,pZEB1作为胃癌预后的决定因素,可能为传统的腹腔灌洗细胞学检查增添有价值的信息。